The risk of atherosclerosis in patients with chronic kidney disease

By Olechnowicz-Tietz Sylwia   Gluba Anna   Paradowska Anna   Banach Maciej   Rysz Jacek  

International Urology and Nephrology, Vol. 45, Iss. 6, 2013-12 ,pp. : 1605-1612

Springer Publishing Company

Access to resources Recommend Favorite

Vitamin D Status and Mortality Risk in Patients with Chronic Kidney Disease

By Santoro Domenico   Gitto Lara   Ferraro Alessandro   Satta Ersilia   Savica Vincenzo   Bellinghieri Guido  

Renal Failure, Vol. 33, Iss. 2, 2011-03 ,pp. : 184-191

Informa Healthcare

Access to resources Recommend Favorite

Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease

By Nitta Kosaku   Iimuro Satoshi   Imai Enyu   Matsuo Seiichi   Makino Hirofumi   Akizawa Tadao   Watanabe Tsuyoshi   Ohashi Yasuo   Hishida Akira  

Clinical and Experimental Nephrology, Vol. 17, Iss. 5, 2013-10 ,pp. : 730-742

Springer Publishing Company

Access to resources Recommend Favorite

Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin

By Post James   Wilkes Barry   Michelis Michael  

International Urology and Nephrology, Vol. 38, Iss. 3-4, 2006-12 ,pp. : 719-723

Springer Publishing Company

Access to resources Recommend Favorite

Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease

By Ueda Seiji   Yamagishi Sho-ichi   Matsumoto Yuriko   Fukami Kei   Okuda Seiya  

Clinical and Experimental Nephrology, Vol. 11, Iss. 2, 2007-06 ,pp. : 115-121

Springer Publishing Company

Access to resources Recommend Favorite